Recombinant activated factor VII: a solution to refractory haemorrhage in vascular surgery?

Warren, O J; Alcock, E M H; Choong, A M T L; Leff, D R; Van Herzeele, I; Darzi, A W; Athanasiou, T; Cheshire, N J W

Warren, O J; Alcock, E M H; Choong, A M T L; Leff, D R; Van Herzeele, I; Darzi, A W; Athanasiou, T; Cheshire, N J W.

Affiliation

Warren OJ; Department of BioSurgery and Surgical Technology, Imperial College, London, United Kingdom. o.warren@imperial.ac.uk

Eur J Vasc Endovasc Surg ; 35(2): 145-52, 2008 Feb.

Article in En | MEDLINE | ID: mdl-17964194

Subject(s)

Coagulants/therapeutic use; Factor VIIa/therapeutic use; Postoperative Hemorrhage/prevention & control; Vascular Surgical Procedures/adverse effects; Adult; Aged; Aged, 80 and over; Coagulants/administration & dosage; Coagulants/adverse effects; Drug Administration Schedule; Erythrocyte Transfusion; Factor VIIa/administration & dosage; Factor VIIa/adverse effects; Female; Humans; Male; Middle Aged; Postoperative Hemorrhage/etiology; Postoperative Hemorrhage/mortality; Recombinant Proteins/administration & dosage; Recombinant Proteins/adverse effects; Recombinant Proteins/therapeutic use; Research Design; Thrombosis/chemically induced; Treatment Outcome

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Vascular Surgical Procedures / Coagulants / Factor VIIa / Postoperative Hemorrhage Type of study: Clinical_trials / Etiology_studies / Prognostic_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Eur J Vasc Endovasc Surg Year: 2008 Document type: Article

Search on Google

XML

PubMed Links